- RecruitingPHASE1, PHASE2
AGILE (Early Phase Platform Trial for COVID-19)
The AGILE trial is exploring new treatments for COVID-19. It tests several different medicines to see which ones are safe and work best. Researchers can easily add new promising drugs to the study as they are discovered, aiming to find effective ways to tackle the virus.
For: Covid19South Africa · United Kingdom - RecruitingPHASE3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
This study is testing a new medicine, Molnupiravir, to see if it can stop people at high risk of severe COVID-19 from becoming very ill. It's for people who can't take other COVID-19 treatments. We want to find out if it works better than a dummy treatment.
For: Coronavirus Disease (COVID-19)United States · Argentina · Brazil - RecruitingPHASE3
Randomised Evaluation of COVID-19 Therapy
The RECOVERY trial looks at treatments for serious lung infections like pneumonia, including COVID-19. It helps doctors find the best ways to help hospitalised patients get better and reduce their risk of dying. Many treatments have been tested, and some have been found to be very helpful.
For: PneumoniaBelgium · Estonia · France